Intellectual Property - March 14, 2025
QureTech Bio granted European patent for new class of antibacterials
The company has been granted a patent by the European Patent Office (EPO) for GmPcides, a new class of synthetic antibacterials.
Intellectual Property - March 5, 2025
SynAct Pharma granted US patent
The United States Patent and Trademark Office (USPTO) has issued US patent 12,239,631 with claims covering the crystal form of resomelagon (AP1189) currently undergoing development in clinical phase 2b.
Intellectual Property - March 5, 2025
Mucocort granted patent in Australia
The company has been granted a patent in Australia for its medical technology innovation, marking a significant milestone in its international expansion it states.
Intellectual Property - February 18, 2025
Dignitana expands IP with new patent in Korea
Dignitana has received a Notice of Allowance from the Korean Intellectual Property Office for a patent titled “Scalp Cooling Apparatus, Method and System.”
Biotech Business - January 22, 2025
South Korea to grant precision medicine patent to Diamyd Medical
The South Korean Patent Office will grant a patent protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients with the HLA DR4-DQ8 genetic marker.
Intellectual Property - December 18, 2024
Q&A Orexo: Patent litigation
Orexo has recently entered a settlement agreement with Sun Pharmaceuticals Industries to resolve a patent litigation regarding the company's Zubsolv sublingual tablet for the treatment of opioid use disorder in the US. NLS asked Nikolaj Sørensen, CEO of Orexo, about the impact of this settlement and his thoughts on the patent litigation process and generic challenges.
